Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07734428

Inflammation and Diabetes: Evaluating Antioxidant Levels

Conditions: Diabete Mellitus, Diabete Type 2, Inflamation, Systemic Inflammation, Dietary Inflammatory Index (DII), Systemic Inflammation Markers

Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Enrollment: 180
Sponsor: Istanbul Bilgi University

Location: Gaziosmanpasa Training and Research Hospital Istanbul

Summary

The goal of this observational, cross-sectional study is to evaluate the relationships between dietary total antioxidant capacity, systemic inflammatory response markers, and nutritional parameters in adult patients with Type 2 Diabetes (T2DM). Participants will be classified into controlled (HbA1c \< %7) and uncontrolled (HbA1c ≥ %7) diabetes groups based on their glycemic control. The main questions it aims to answer are: Does dietary antioxidant capacity affect systemic inflammation levels and metabolic parameters? Is there a relationship between nutritional risk status and inflammatory response in T2DM patients?

Eligibility Criteria

Inclusion Criteria: * Adults aged 18 and older diagnosed with Type 2 Diabetes. * Individuals whose biochemical analyses have been performed by a physician within the last 1 month. * Individuals willing to participate voluntarily. Exclusion Criteria: * Missing required laboratory data in the last 1 month. * Presence of acute infection or inflammatory disease. * Advanced kidney or liver failure. * Active malignancy or receiving chemotherapy/radiotherapy. * Pregnant and lactating women. * Use of antioxidant/vitamin-mineral supplements. * Receiving special diet therapies (e.g., time-restricted, ketogenic, or elimination diet). * Advanced cognitive impairment or communication difficulties.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07734428). StuddyBuddy aggregates publicly available trial information.